Literature DB >> 7438462

Glucose and free fatty acid turnover in thyrotoxicosis and hypothyroidism, before and after treatment.

J Saunders, S E Hall, P H Sönksen.   

Abstract

Glucose and free fatty acid (FFA) turnover (RT) were measured by isotopic methods in groups of patients with thyrotoxicosis and hypothyroidism and compared with normal subjects. Patients with thyrotoxicosis were then studied after treatment with oral propranolol and again after treatment with carbimazole. Patients with hypothyroidism were studied again after treatment with thyroxine. Glucose RT was increased by about a third in thyrotoxicosis (12.7 mumol. min.-1 kg-1 +/- 1.0 SEM compared to 9.5 +/- 0.5 in normal subjects) while FFA RT was doubled (12.5 mumol. min.-1 kg-1 +/- 1.2 compared to 6.3 +/- 0.9 in normals). Propranolol was without effect, but carbimazole normalized these variables. In hypothyroidism both glucose and FFA RT were normal (9.1 +/- 0.7 and 6.7 +/- 0.9 respectively). Mean glucose and FFA RT both rose following thyroxine treatment, but not significantly; the post-treatment values remaining within the normal range (10.3 +/- 0.7 and 7.0 +/- 1.3 respectively). Oxidation of FFA, as estimated by 14CO2 excretion, was increased in thyrotoxicosis (42.8% +/- 2.9 SEM compared to 34.8 +/- 2.3 in normal subjects) and fell with carbimazole treatment (34.7 +/- 4.1). In hypothyroid subjects FFA oxidation increased following thyroxine treatment (from 34.4 +/- 4.1). In hypothyroid subjects FFA oxidation increased following thyroxine treatment (from 34.4 +/- 3.3 to 46.2 +/- 3.6).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7438462     DOI: 10.1111/j.1365-2265.1980.tb01020.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  11 in total

1.  Insulin binding to monocytes and in vivo peripheral insulin sensitivity are normal in Graves' disease.

Authors:  P Cavallo-Perin; A Bruno; C Bozzo; L Boine; P Estivi; V Martina; G Gallone; G Pagano
Journal:  J Endocrinol Invest       Date:  1988-12       Impact factor: 4.256

2.  Beta-adrenoceptor-agonist and insulin actions on glucose metabolism in rat skeletal muscle in different thyroid states.

Authors:  G D Dimitriadis; S J Richards; M Parry-Billings; B Leighton; E A Newsholme; R A Challiss
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

3.  Thyroid hormone action on intermediary metabolism. Part II: Lipid metabolism in hypo- and hyperthyroidism.

Authors:  M J Müller; H J Seitz
Journal:  Klin Wochenschr       Date:  1984-01-16

Review 4.  Thyroid hormone action on intermediary metabolism. Part I: respiration, thermogenesis and carbohydrate metabolism.

Authors:  M J Müller; H J Seitz
Journal:  Klin Wochenschr       Date:  1984-01-02

5.  Experimental hyperthyroidism does not induce hepatic insulin resistance in the miniature pig.

Authors:  M J Müller; J Möring; H J Seitz
Journal:  Biochem J       Date:  1986-03-15       Impact factor: 3.857

Review 6.  Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Authors:  J Feely; N Peden
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

7.  Lipid transport in the human newborn. Palmitate and glycerol turnover and the contribution of glycerol to neonatal hepatic glucose output.

Authors:  P F Bougnères; I E Karl; L S Hillman; D M Bier
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

8.  Na+K+ATPase activity and ouabain binding sites in erythrocytes in hyperthyroidism before and after treatment.

Authors:  C De Riva; S Chen; F Virgili; F Frigato
Journal:  J Endocrinol Invest       Date:  1992-05       Impact factor: 4.256

9.  Substrate cycling between gluconeogenesis and glycolysis in euthyroid, hypothyroid, and hyperthyroid man.

Authors:  G I Shulman; P W Ladenson; M H Wolfe; E C Ridgway; R R Wolfe
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

10.  Decreased insulin receptor binding in hyperthyroidism.

Authors:  G Schernthaner; R Prager; M Weissel; R Höfer
Journal:  Klin Wochenschr       Date:  1984-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.